Follow
Ivan Peyron
Ivan Peyron
INSERM U1176
Verified email at inserm.fr
Title
Cited by
Cited by
Year
A hemophilia A mouse model for the in vivo assessment of emicizumab function
S Ferrière, I Peyron, OD Christophe, C Kawecki, C Casari, V Muczynski, ...
Blood, The Journal of the American Society of Hematology 136 (6), 740-748, 2020
422020
To serve and protect: the modulatory role of von Willebrand factor on factor VIII immunogenicity
RB Hartholt, AS van Velzen, I Peyron, A Ten Brinke, K Fijnvandraat, ...
Blood reviews 31 (5), 339-347, 2017
422017
Development of inhibitory antibodies to therapeutic factor VIII in severe hemophilia A is associated with microsatellite polymorphisms in the HMOX1 promoter
Y Repessé, I Peyron, JD Dimitrov, S Dasgupta, EF Moshai, C Costa, ...
haematologica 98 (10), 1650, 2013
422013
The C1 and C2 domains of blood coagulation factor VIII mediate its endocytosis by dendritic cells
B Gangadharan, M Ing, S Delignat, I Peyron, M Teyssandier, SV Kaveri, ...
Haematologica 102 (2), 271, 2017
412017
Antibody-mediated catalysis: induction and therapeutic relevance
A Mahendra, M Sharma, DN Rao, I Peyron, C Planchais, JD Dimitrov, ...
Autoimmunity reviews 12 (6), 648-652, 2013
302013
Heme binds to factor VIII and inhibits its interaction with activated factor IX
Y Repessé, JD Dimitrov, I Peyron, EF Moshai, L Kiger, S Dasgupta, ...
Journal of Thrombosis and Haemostasis 10 (6), 1062-1071, 2012
282012
Storage-induced platelet apoptosis is a potential risk factor for alloimmunization upon platelet transfusion
A Saris, I Peyron, PF Van der Meer, TB Stuge, JJ Zwaginga, SM Van Ham, ...
Frontiers in immunology 9, 1251, 2018
252018
Hunting down factor VIII in the immunopeptidome
RB Hartholt, I Peyron, J Voorberg
Cellular Immunology 301, 59-64, 2016
242016
Complement C3 is a novel modulator of the anti-factor VIII immune response
J Rayes, M Ing, S Delignat, I Peyron, L Gilardin, CW Vogel, DC Fritzinger, ...
haematologica 103 (2), 351, 2018
202018
Comparative profiling of HLA-DR and HLA-DQ associated factor VIII peptides presented by monocyte-derived dendritic cells
I Peyron, RB Hartholt, L Pedró-Cos, F van Alphen, A Ten Brinke, N Lardy, ...
Haematologica 103 (1), 172, 2018
202018
Mass spectrometry-assisted identification of ADAMTS13-derived peptides presented on HLA-DR and HLA-DQ
J Hrdinová, FC Verbij, PHP Kaijen, RB Hartholt, F van Alphen, N Lardy, ...
Haematologica 103 (6), 1083, 2018
182018
Enhanced uptake of blood coagulation factor VIII containing immune complexes by antigen presenting cells
RB Hartholt, A Wroblewska, E Herczenik, I Peyron, A Ten Brinke, ...
Journal of Thrombosis and Haemostasis 15 (2), 329-340, 2017
182017
The ADAMTS131239–1253 peptide is a dominant HLA-DR1-restricted CD4+ T-cell epitope
L Gilardin, S Delignat, I Peyron, M Ing, YC Lone, B Gangadharan, ...
haematologica 102 (11), 1833, 2017
162017
Haemarthrosis and arthropathy do not favour the development of factor VIII inhibitors in severe haemophilia A mice.
I Peyron, JD Dimitrov, S Delignat, B Gangadharan, C Planchais, ...
Haemophilia 21 (1), 2015
152015
Relevance of the materno-fetal interface for the induction of antigen-specific immune tolerance
A Mimoun, S Delignat, I Peyron, V Daventure, M Lecerf, JD Dimitrov, ...
Frontiers in immunology 11, 810, 2020
142020
Non-inhibitory antibodies inducing increased emicizumab clearance in a severe hemophilia A inhibitor patient
A Harroche, T Sefiane, M Desvages, D Borgel, D Lasne, C Casari, ...
Haematologica 106 (8), 2287, 2021
122021
The class I scavenger receptor CD163 promotes internalization of ADAMTS13 by macrophages
FC Verbij, N Sorvillo, PHP Kaijen, J Hrdinova, I Peyron, R Fijnheer, ...
Blood advances 1 (5), 293-305, 2017
122017
Camelid‐derived single‐chain antibodies in hemostasis: Mechanistic, diagnostic, and therapeutic applications
I Peyron, C Kizlik‐Masson, MD Dubois, S Atsou, S Ferrière, CV Denis, ...
Research and Practice in Thrombosis and Haemostasis 4 (7), 1087-1100, 2020
112020
Oxidation of factor VIII increases its immunogenicity in mice with severe hemophilia A
I Peyron, JD Dimitrov, S Delignat, B Gangadharan, A Srivastava, ...
Cellular Immunology 325, 64-68, 2018
62018
Biochemical characterization and immunogenicity of Neureight, a recombinant full-length factor VIII produced by fed-batch process in disposable bioreactors
S Delignat, I Peyron, M El Ghazaly, SV Kaveri, J Rohde, F Mueller, ...
Cellular Immunology 331, 22-29, 2018
42018
The system can't perform the operation now. Try again later.
Articles 1–20